Cargando…
Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine—Burkina Faso, 2011–2013
BACKGROUND: Following introduction of Haemophilus influenzae type b vaccine in 2006 and serogroup A meningococcal conjugate vaccine in 2010, Streptococcus pneumoniae (Sp) became the leading cause of bacterial meningitis in Burkina Faso. We describe bacterial meningitis epidemiology, focusing on pneu...
Autores principales: | Kambiré, Dinanibè, Soeters, Heidi M., Ouédraogo-Traoré, Rasmata, Medah, Isaïe, Sangare, Lassana, Yaméogo, Issaka, Sawadogo, Guetawendé, Ouédraogo, Abdoul-Salam, Hema-Ouangraoua, Soumeya, McGee, Lesley, Srinivasan, Velusamy, Aké, Flavien, Congo-Ouédraogo, Malika, Sanou, Soufian, Ba, Absatou Ky, Novak, Ryan T., Van Beneden, Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104358/ https://www.ncbi.nlm.nih.gov/pubmed/27832151 http://dx.doi.org/10.1371/journal.pone.0166384 |
Ejemplares similares
-
Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis—Burkina Faso, 2014–2015
por: Kambiré, Dinanibè, et al.
Publicado: (2018) -
Evaluation of pneumococcal meningitis clusters in Burkina Faso and implications for potential reactive vaccination
por: Soeters, Heidi M., et al.
Publicado: (2020) -
Molecular characterization of invasive meningococcal isolates in Burkina Faso as the relative importance of serogroups X and W increases, 2008–2012
por: Retchless, Adam C., et al.
Publicado: (2018) -
Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign
por: Diallo, Alpha Oumar, et al.
Publicado: (2017) -
Identification of Streptococcus suis Meningitis by Direct Triplex Real-Time PCR, Burkina Faso
por: Ouattara, Mahamoudou, et al.
Publicado: (2020)